(Q45989102)

English

Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.

scientific article published on 20 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

author name string

M Ishihara

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

C Nishida

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Y Tashiro

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

I Gritli

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

J Rosenkvist

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

M Koizumi

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Y Okaji

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

R Yamamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

H Yagita

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

K Okumura

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

M Nishikori

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

K Wanaka

12

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Y Tsuda

13

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Y Okada

14

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

H Nakauchi

15

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

B Heissig

16

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

K Hattori

17

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

publication date

20 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

26

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

332-339

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

https://scigraph.springernature.com/pub.10.1038/leu.2011.203

0 references

Matrix metalloproteinases and oral cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

The plasminogen fibrinolytic pathway is required for hematopoietic regeneration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Polarized immune responses differentially regulate cancer development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Stromal gene signatures in large-B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Inflammatory cells and immune microenvironment in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Reduced transplant arteriosclerosis in plasminogen-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Eosinophils and oral squamous cell carcinoma: a short review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

21 January 2018

Plasminogen activation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.203

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2011.203

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/21931322

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45989102&oldid=1456810341"